This week, Wheel rolled out a new AI-powered platform designed to provide patients with more holistic and seamless virtual care journeys. The platform, called Horizon, aims to help the startup’s customers rapidly scale virtual care programs to meet growing patient demand.

The post Wheel’s New AI Platform Seeks to Power the New Era of Virtual Care appeared first on MedCity News.

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff, specifically for the 18.8 million annual soft tissue surgical procedures not currently supported by available telerobotic systems.

The post Why Is Moon Surgical’s New Commercial Robot System Important? appeared first on MedCity News.

Stitch PEO — a startup built at Redesign Health — officially launched and announced that it has raised $8.75 million in seed funding. The company is a professional employer organization for independent medical practices, designed to improve recruiting, hiring, onboarding, and other human resources processes.

The post New Startup Launches to Reduce Medical Practices’ HR Burden appeared first on MedCity News.

CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.

The post INVEST Pitch Perfect Spotlight: CoraVie Medical’s Mission to Transform the Way We Monitor Blood Pressure appeared first on MedCity News.

The contest — which will include startup focusing on pediatric and teen behavioral health — will take place at Pegasus Park in Dallas on September 18. The deadline to submit applications is July 10, so apply today!

The post To All Pediatric and Teen Mental Health Startups Seeking Investors: Apply for MedCity’s Pitch Perfect Contest! appeared first on MedCity News.

Here is a selection of recent executive hires, promotions, retirements and layoffs occurring across the healthcare industry.

The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

CinRx Pharma’s most prominent spinout is CinCor Pharma, which was acquired by AstraZeneca last year. The startup creator will apply its new capital toward current programs and to expand to additional areas of unmet medical need.

The post CinRx Pharma Corrals $73M to Continue ‘Hub and Spoke’ Model of Startup Formation appeared first on MedCity News.

Merck’s EyeBio acquisition brings a lead program ready for pivotal testing in diabetic macular edema. The therapy could pose competition to Eylea, the blockbuster Regeneron Pharmaceuticals eye drug.

The post Merck Sees Pipeline Diversification Opportunity in $1.3B EyeBio Acquisition appeared first on MedCity News.

Fem Therapeutics won the audience choice award in the Canadian PItch contest at MedCity INVEST in Chicago this week. It competed with Reach Orthopaedics , PragmaClin Research, and OPTT Health.

The post Canadian Women’s Health Medtech Startup Wins Over Audience at MedCity INVEST appeared first on MedCity News.

During a panel at MedCity News’ INVEST conference, venture capitalists shared some of their takes on today’s healthcare funding landscape — including their thoughts on AI and the industry’s slower investment pace.

The post 4 Things Digital Health Investors Need To Get Off Their Chest appeared first on MedCity News.

Centivo, a health plan that sells to self-funded employers, acquired virtual-first primary care startup Eden Health. With this acquisition, Centivo now serves more than 160 employers in all 50 states.

The post Centivo Acquires a Primary Care Startup, Despite Others Fleeing the Space appeared first on MedCity News.

Saint Luke’s Mid America Heart Institute launched a new solution on its care platform to help patients who have AFib or are at risk of developing the condition. The program, which was developed with digital health startup Story Health, seeks to engage patients between clinic visits.

The post Saint Luke’s, Story Health Roll Out New AFib Program appeared first on MedCity News.

Watershed Health closed a $13.6 million funding round this week. The New Orleans-based company seeks to improve care coordination by connecting providers of all types across the healthcare system.

The post Watershed Health Raises $14M For Its Care Coordination Platform appeared first on MedCity News.

Johnson & Johnson’s Proteologix acquisition adds a pipeline of bispecific antibodies, including an experimental treatment for asthma and atopic dermatitis. It’s the latest M&A deal involving molecules addressing TSLP, a key signaling protein involved in inflammation.

The post J&J Joins Chase for Hot Immunology Target With $850M Proteologix Acquisition appeared first on MedCity News.

Blackstone Life Sciences startup Uniquity Bio emerged from stealth with an in-licensed drug candidate that could treat a wide range of immunology and inflammation indications. The antibody’s target puts it in competition with drugs from AstraZeneca, Pfizer, and Sanofi.

The post Blackstone Unveils Immunology Startup With $300M and a Phase 2-Ready Drug From Merck appeared first on MedCity News.

SmarterDx — an AI startup that provides clinical review and quality audits for medical claims — closed a $50 million Series B funding round, bringing its total funding to date to $71 million.

The post SmarterDx Rakes In $50M For Its AI That Helps Hospitals Capture More Revenue appeared first on MedCity News.

As more hospitals across the country shut down their maternity wards, a Sutter Health-owned hospital in Berkeley has taken proactive steps to ensure it can continue providing care for the pregnant people in its community. The hospital partnered with Millie, a Berkeley-based startup offering hybrid maternal care from midwives and doulas.

The post How Millie Partners with Health Systems to Expand Access to Midwifery appeared first on MedCity News.

The boutique healthcare investment conference in Chicago is scheduled for May 21-22. Space is limited so register today!

The post Healthcare Investment Trends Take Center Stage at MedCity INVEST appeared first on MedCity News.

Eli Lilly-partnered Lycia Therapeutics will use its Series C financing to continue developing its internal pipeline of protein-degrading drugs. The startup is working to reach the clinic with drugs for autoimmune and inflammatory disorders.

The post Lycia Therapeutics Lands $106M for Protein Degraders That Treat Autoimmune & Inflammatory Diseases appeared first on MedCity News.

Check out news from Alpha Sophia, Triomics, In-House Health, and Humanaut Health.

The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

Pepper Bio has licensed rights to lerociclib, a molecule that G1 Therapeutics designed to offer dosing and safety advantages over approved therapies in the same drug class. EQRx previously held rights to the drug, but returned them after the company was acquired last year.

The post Pepper Bio’s ‘Google Maps for Drug Discovery’ Finds Way to Potential New Liver Cancer Drug appeared first on MedCity News.

Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.

The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.

Enlaza Therapeutics’ drugs form covalent bonds that lock the therapy onto its target. With cancer as its initial focus, the startup contends its approach could offer safety and efficacy advantages compared to currently available targeted therapies.

The post J.P. Morgan Leads $100M Financing for Startup’s R&D of Covalent Biologic Drugs for Cancer appeared first on MedCity News.

The group of four healthcare startups spans women’s health, orthopedics, remote patient monitoring for Parkinson’s disease, AI, and 3D printing. David Kereiakes, Managing Partner, Windham Venture Partners will moderate the session.

The post Four Innovative Canadian Medtech Startups to Watch at MedCity INVEST appeared first on MedCity News.

Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding comes in tranches, from $300,000 – $4 million, based upon the stage of development and likelihood of the end product “moving the needle” in healthcare.

The post An Overview of the Nation’s Largest SEED Fund appeared first on MedCity News.

Check out news from Alpha Sophia, Handl Health, Alaffia Health, and Summer Health

The post StartUPDATES: New Developments from Healthcare Startups appeared first on MedCity News.

Regeneron Pharmaceuticals is collaborating with CRISPR technologies startup Mammoth Biosciences to develop in vivo gene-editing therapies. The deal marks the third pharmaceutical industry partnership for Mammoth, which initially focused on developing CRISPR-based diagnostics.

The post Regeneron Bets $100M That Mammoth’s CRISPR Tech Can Deliver on Next Wave of Genetic Medicines appeared first on MedCity News.

Two Japanese pharmaceutical companies and a bank are teaming up to form a joint venture to advance therapeutic discoveries from academia. The focus will be innovation from universities in Japan.

The post Takeda, Astellas & Sumitomo Mitsui Form Joint Venture to Lift Japanese Innovation From ‘Valley of Death’ appeared first on MedCity News.

The diagnostics/medical device track focuses on cardiology this year.

The post Which Medtech Startups Will Take Part in the MedCity INVEST Pitch Perfect Contest? appeared first on MedCity News.

Ilant Health extended its seed round from $3 million to $5.5 million. The company garnered interest from LifeX Ventures, Celtic House Asia Partners and Cornucopian Capital.

The post Ilant Health Raises Extended Seed Round of $5.5M for Obesity Management Platform appeared first on MedCity News.